| Summary: | LYDEX, which is a hydrogel composed of aldehyde-functionalized dextran and succinic anhydride-treated ε-poly-L-lysine, was previously developed by our group as a self-degradable adhesive with an excellent functionality. As a result, this hydrogel has been investigated for a wide range of medical applications, including hemostatic agents, sealants, wound dressings for endoscopes, and anti-adhesion materials. Previously, the unique potential of LYDEX to control the in vivo degradation rate depending on its composition was verified for use in anti-adhesion applications. Although the gel thickness also plays a significant role in determining the degradation rate, this issue was not sufficiently investigated in previous studies. Thus, in the current study, the optimal LYDEX dose (film thickness) for maximizing the anti-adhesion material performance was verified using a rabbit colon model and it was confirmed that the gel film thickness affects the degradation period and anti-adhesion effect. The obtained results suggest the potential for designing LYDEX materials suitable for application at a wider range of in vivo treatment sites, which could be extremely valuable for the development and use of novel anti-adhesion materials with adequate hemostatic and sealant performances.
|
|---|